TVWM
CLBT icon

Tower View Wealth Management’s Cellebrite CLBT Stock Holding History

Tower View Wealth Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-130,915
Closed -$2.09M – 181
2025
Q2 		$2.09M Sell
130,915
-40
-0% -$713 1.09% 35
2025
Q1 		$2.54M Sell
130,955
-1,352
-1% -$28.5K 1.48% 31
2024
Q4 		$2.91M Buy
132,307
+1,660
+1% +$31.9K 1.54% 32
2024
Q3 		$2.2M Buy
130,647
+1,500
+1% +$22.3K 1.2% 39
2024
Q2 		$1.54M Buy
129,147
+7,542
+6% +$84.3K 0.89% 39
2024
Q1 		$1.35M Buy
+121,605
New +$1.24M 0.79% 43

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Tower View Wealth Management's CLBT Position: Q3 2025 in Review

Tower View Wealth Management sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 130,915 shares — an estimated $2.09M sold.

Tower View Wealth Management first reported a position in CLBT in Q1 2024 and held it in 6 quarters. The position peaked at $2.91M in Q4 2024. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Tower View Wealth Management reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Tower View Wealth Management sold 130,915 Cellebrite shares in Q3 2025, an estimated $2.09M.
  • Tower View Wealth Management first reported a position in Cellebrite in Q1 2024 and held it in 6 quarters.
  • Tower View Wealth Management's Cellebrite position peaked at $2.91M in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Tower View Wealth Management's 13F filing for Q3 2025, filed 16 Oct 2025.